Results 31 to 40 of about 15,537,279 (243)

Target Temperature Management for Postcardiac Arrest Patients [PDF]

open access: yesTherapeutic Hypothermia and Temperature Management, 2014
Dear Editor: We read with interest the Letter to the Editor (Perchiazzi et al., 2014) highlighting limitations in the Nielsen study (Nielsen et al., 2013). Here we identify additional major biases that could affect practitioners' interpretations and decisions.
Mayuki, Aibiki   +4 more
openaire   +2 more sources

Insights from patients screened but not randomised in the HYPERION trial

open access: yesAnnals of Intensive Care, 2021
Background Few data are available about outcomes of patients screened for, but not enrolled in, randomised clinical trials. Methods We retrospectively reviewed patients who had non-inclusion criteria for the HYPERION trial comparing 33 °C to 37 °C in ...
J. B. Lascarrou   +17 more
doaj   +1 more source

Targeted Temperature Management for Treatment of Cardiac Arrest [PDF]

open access: yesCurrent Treatment Options in Cardiovascular Medicine, 2020
Cardiac arrest is a common condition associated with high mortality and a substantial risk of neurological injury among survivors. Targeted temperature management (TTM) is the only strategy shown to reduce the risk of neurologic disability cardiac arrest patients.
Tyler P. Rasmussen   +2 more
openaire   +2 more sources

Targeted Temperature Management in Post Cardiac Arrest

open access: yes, 2023
Out-of-hospital cardiac arrests occur in 350,000 patients annually and carry a 90% mortality rate. International critical care societies recommend targeted temperature management for patients who suffer a cardiac arrest and remain comatose (Glasgow Coma ...
Spragins, Abigail
core   +1 more source

Targeted Temperature Management Following Out-of-Hospital Cardiac Arrest – A Systematic Review and Network Meta-Analysis of Temperature Targets

open access: yes, 2021
Systematic review and network meta-analysis with the objective of evaluating the comparative efficacy of four temperature targets for targeted temperature management in comatose survivors of out-of-hospital cardiac ...
Daniel Brodie   +19 more
core   +1 more source

Impact of protocolized postarrest care with targeted temperature management on the outcomes of cardiac arrest survivors without temperature management

open access: yesAnnals of Medicine, 2022
Introduction Protocolized postarrest care that includes targeted temperature management (TTM) improves survival and neurological outcomes in cardiac arrest survivors.
Dean-An Ling   +8 more
doaj   +1 more source

Temperature control in adults after cardiac arrest: a survey of current clinical practice in Germany

open access: yesCritical Care, 2023
Background Temperature control is recommended after out of hospital cardiac arrest (OHCA) by international guidelines. This survey aimed to investigate current clinical practice and areas of uncertainty.
Kevin Roedl   +6 more
doaj   +1 more source

Targeted Temperature Management for In-hospital Cardiac Arrest Caused by Thyroid Storm: A Case Report

open access: yesFrontiers in Cardiovascular Medicine, 2021
Background: Malignant ventricular arrhythmias caused by thyroid storm, such as ventricular tachycardia (VT) or ventricular fibrillation (VF), which are life-threatening, are rare. We report the case of a patient who suffered from cardiac arrest caused by
Yuanwei Fu   +7 more
doaj   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy